Cargando…

Influence of HLA Matching on the Efficacy of Allogeneic Mesenchymal Stromal Cell Therapies for Osteoarthritis and Degenerative Disc Disease

BACKGROUND: The necessity for more effective therapies for chronic osteoarticular diseases has led to the development of treatments based on mesenchymal stem cells (MSCs), the natural precursors of musculoskeletal tissue. Treatments with autologous MSCs yielded excellent results, with nearly 70% imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Sancho, Javier, Sánchez, Ana, Vega, Aurelio, Noriega, David C., Nocito, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Cell Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585421/ https://www.ncbi.nlm.nih.gov/pubmed/28894792 http://dx.doi.org/10.1097/TXD.0000000000000724

Ejemplares similares

Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations
por: Togarrati, Padma Priya, et al.
Publicado: (2019)

Cross‐matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting
por: Rowland, Aileen L., et al.
Publicado: (2020)

De Novo Circulating Antidonor's Cell Antibodies During Induced Acute Rejection of Allogeneic Myofibers in Myogenic Cell Transplantation: A Study in Nonhuman Primates
por: Skuk, Daniel, et al.
Publicado: (2017)

The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study
por: de Greef, Georgine E., et al.
Publicado: (2018)

Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
por: Najar, Mehdi, et al.
Publicado: (2020)

Mutant B2M‐HLA‐E and B2M‐HLA‐G fusion proteins protects universal chimeric antigen receptor‐modified T cells from allogeneic NK cell‐mediated lysis
por: Guo, Yelei, et al.
Publicado: (2021)

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
por: Zurko, Joanna, et al.
Publicado: (2022)

Pro-regenerative Dialogue Between Macrophages and Mesenchymal Stem/Stromal Cells in Osteoarthritis
por: Bohaud, Candice, et al.
Publicado: (2021)

Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis
por: Lamo-Espinosa, José María, et al.
Publicado: (2021)

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation
por: Watanabe, Marika, et al.
Publicado: (2022)

Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic, and degenerative intervertebral discs: a proteomic analysis
por: Wangler, Sebastian, et al.
Publicado: (2021)

Homing of vertebral‐delivered mesenchymal stromal cells for degenerative intervertebral discs repair – an in vivo proof‐of‐concept study
por: Schol, Jordy, et al.
Publicado: (2022)

Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation
por: Heinz, Amadeus T., et al.
Publicado: (2023)

Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias
por: Fernandes, Sarah, et al.
Publicado: (2009)

Quantification of biological variation in blood‐based therapy – a summary of a meta‐analysis to inform manufacturing in the clinic
por: Thurman‐Newell, J. A., et al.
Publicado: (2015)

Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago
por: Tekin, Zehra, et al.
Publicado: (2016)

The Optimization of Short-Term Hepatocyte Preservation Before Transplantation
por: Fukuoka, Kengo, et al.
Publicado: (2017)

A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction
por: Vrtovec, Bojan, et al.
Publicado: (2022)

The 17‐gene stemness score associates with relapse risk and long‐term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia
por: Kim, Dennis D. H., et al.
Publicado: (2022)

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage‐specific chimerism analysis
por: Lindahl, Hannes, et al.
Publicado: (2022)

Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation
por: Rambaldi, Benedetta, et al.
Publicado: (2022)

Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells
por: Fang, Karen Kai-Lin, et al.
Publicado: (2023)

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
por: Anna, François, et al.
Publicado: (2021)

Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1(157-165) tumor-specific peptide
por: Shenderov, Eugene, et al.
Publicado: (2021)

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
por: Vasileiou, Spyridoula, et al.
Publicado: (2022)

'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
por: Sinha, Debottam, et al.
Publicado: (2021)

Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
por: Schroeder, Thomas, et al.
Publicado: (2023)

Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation
por: Tassi, Elena, et al.
Publicado: (2022)

Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
por: Tokatlian, Talar, et al.
Publicado: (2022)

Attitudes Towards Standardization of Mesenchymal Stromal Cells—A Qualitative Exploration of Expert Views
por: Wilson, Alison J, et al.
Publicado: (2023)

Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortality
por: Scheidler, Lucia, et al.
Publicado: (2023)

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy
por: Plewa, Natalia, et al.
Publicado: (2023)

Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy
por: Black, Amanda B., et al.
Publicado: (2015)

Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
por: Liu, Xin, et al.
Publicado: (2022)

Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
por: Balakrishnan, Balaji, et al.
Publicado: (2020)

CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023)

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma
por: Immisch, Lena, et al.
Publicado: (2022)

Immune response to allogeneic equine mesenchymal stromal cells
por: Kamm, J. Lacy, et al.
Publicado: (2021)

CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
por: Dragon, Anna Christina, et al.
Publicado: (2020)

Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy
por: Xiong, Chengjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umvucn74rjqshvu4u0jk8ktrh9